GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Essity
How did Essity transform from a Swedish pulp group into a global hygiene leader?
In 2017, SCA split into two listed companies, creating Essity to focus solely on hygiene and health. Built on roots dating to 1929, Essity shed timber cycles to become a consumer-focused, innovation-driven company. Its shift enabled rapid global expansion.
Essity’s 2017 demerger allowed concentrated investment in brands like TENA and Tork, driving growth to 147 billion SEK in 2024 and presence in 150 countries. See strategic analysis at Essity Porter's Five Forces Analysis.
What is the Essity Founding Story?
Essity’s founding story begins with the establishment of Svenska Cellulosa Aktiebolaget (SCA) on June 17, 1929, created to consolidate fragmented Swedish pulp and paper mills into a single vertically integrated industrial group.
Founding Story: From SCA to Essity origins
Founded by Ivar Kreuger in 1929, SCA united multiple mills to control timber, pulp and export; surviving the 1932 crisis, it later laid the groundwork for Essity company evolution into hygiene and health.
- Founded on June 17, 1929 as Svenska Cellulosa Aktiebolaget (SCA)
- Initiated by Ivar Kreuger to consolidate fragmented pulp and paper mills
- Early products: chemical/mechanical pulp, sawn timber and newsprint
- Post-1932 takeover by Handelsbanken stabilized SCA’s operations
The founding model merged ten forestry companies, including Holmsund, Munksund and Nyhamn, creating a vertically integrated supply chain that enabled export-oriented pulp production and logistical scale.
SCA’s early survival through the Great Depression relied on mill locations near the Gulf of Bothnia and management expertise; those operational efficiencies became core to Essity history and later its move into consumer hygiene.
For details on market positioning and subsequent brand evolution, see Target Market of Essity.
Complete Essity Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
What Drove the Early Growth of Essity?
Early Growth and Expansion traces the company’s shift from forestry and paper into branded hygiene and health products, driven by strategic acquisitions from the 1970s onward.
1975: Strategic pivot
In 1975 the acquisition of Mölnlycke introduced the TENA and Libero brands, marking a decisive move from commodity forestry and paper into personal care and incontinence markets.
1995: European scale-up
The 1995 acquisition of German paper group PWA for 12.3 billion SEK substantially increased European tissue market share and accelerated international expansion during the 1980s–1990s.
2000s: North America and Europe consolidation
Key deals included the 2001 purchase of Georgia-Pacific’s North American tissue business and the 2007 acquisition of Procter & Gamble’s European tissue operations for 512 million EUR, strengthening global footprint.
2012–2017: Market leadership and independence
The 2012 acquisition of Georgia‑Pacific’s European tissue business for 1.32 billion EUR helped hygiene products exceed 80 percent of sales by 2016, leading to the June 2017 spin‑off and listing of Essity on Nasdaq Stockholm.
These milestones form the core of the Essity history and Essity company evolution, mapping key milestones in Essity's history, the timeline of major acquisitions, and the shift that led to the creation of Essity; see Revenue Streams & Business Model of Essity for additional context.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
What are the key Milestones in Essity history?
Milestones, Innovations and Challenges chart Essity company evolution from its 2017 BSN medical acquisition through digital hygiene innovations to strategic divestments and margin-focused pivots, reflecting the company’s shift from volume to value and resilience amid commodity and geopolitical shocks.
| Year | Milestone |
|---|---|
| 2017 | Completed acquisition of BSN medical for 2.74 billion EUR, creating a dedicated Health and Medical segment. |
| 2022 | Faced energy crisis and global pulp price volatility that forced aggressive consumer tissue price increases and compressed margins. |
| 2023 | Completed total exit from the Russian market, recording a significant impairment to align with corporate ethics. |
| 2024 | Divested 52 percent stake in Vinda for approximately 19 billion SEK to focus on higher-growth branded categories. |
| Late 2024 | Reported a shift to a value-based strategy with EBITA margin expansion reaching 13.9 percent. |
Essity history features industry-first products like the Tork Vision Cleaning system, an IoT-enabled, data-driven facility solution that optimizes cleaning cycles and consumable use. The company has been recognized by Corporate Knights among the world’s most sustainable companies for its circularity and emission reductions.
Tork Vision Cleaning
IoT sensors and analytics reduce waste and improve facility uptime through predictive refill and cleaning scheduling.
BSN Medical Integration
Acquisition integrated Leukoplast, Jobst and Cutimed brands, expanding Medical Solutions and value-added healthcare offerings.
Digital Hygiene Services
Platform services link consumables, sensors and procurement data to drive recurring revenue and customer stickiness.
Sustainability Recognition
Named among the world’s most sustainable companies, reflecting reduced CO2 intensity and increased recycled fiber use.
Value-Based Commercial Model
Shift from volume to value prioritizes EBITA margin expansion and higher-margin Personal Care and Medical categories.
Regional Portfolio Optimization
Strategic divestments like Vinda stake sale free capital to invest in branded growth markets.
Key challenges include commodity input volatility—especially pulp prices—and the 2022 energy crisis that squeezed margins and required price hikes across tissue lines. Geopolitical shifts also forced market exits and impairments, accelerating strategic pivots toward higher-margin segments.
Pulp Price Volatility
Sharp swings in global pulp costs drove COGS volatility and pressured gross margins; pass-through pricing lagged market moves.
Energy Crisis Impact
Elevated energy costs in 2022 increased production expenses, forcing across-the-board price increases for consumer tissue products.
Geopolitical Exits
Exit from Russia in 2023 led to significant impairments but aligned operations with corporate governance and ethics.
Margin Pressure in Asia
Lower margins in the Asian tissue market prompted the Growth Strategy of Essity linked divestment of the Vinda stake in 2024.
Transition Risks
Repositioning from volume to value required restructuring costs, channel reconfiguration and renewed brand investments to protect margins.
Supply Chain Constraints
Global logistics and raw material constraints intermittently disrupted production forecasting and inventory optimization.
Essity Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What is the Timeline of Key Events for Essity?
Timeline and Future Outlook: a concise Essity timeline highlights origins in SCA (1929), major hygiene and tissue acquisitions, the 2017 separation and listing, and recent strategic divestments and margin gains; future outlook focuses on aging demographics, sustainability goals and digital health expansion.
| Year | Key Event |
|---|---|
| 1929 | Ivar Kreuger founds Svenska Cellulosa Aktiebolaget (SCA) through a merger of ten forestry companies, laying the industrial foundation for future hygiene operations. |
| 1950 | SCA is listed on the Stockholm Stock Exchange, increasing capital access for expansion. |
| 1975 | Acquisition of Mölnlycke signals entry into hygiene and health, beginning the company's evolution beyond forestry. |
| 1995 | Acquisition of PWA propels the company into a major position in the European tissue market. |
| 2007 | Acquisition of P&G’s European tissue business, including the Tempo brand, broadens consumer tissue reach. |
| 2012 | Purchase of Georgia-Pacific’s European operations for 1.32 billion EUR strengthens tissue capacity and market share. |
| 2017 | SCA splits; Essity is listed as an independent company on Nasdaq Stockholm, focused on hygiene and health. |
| 2017 | Acquisition of BSN medical expands the portfolio into professional wound care and Medical Solutions. |
| 2022 | Acquisitions of Knix and Modibodi position Essity as a leader in leakproof apparel and consumer intimate care innovations. |
| 2023 | Complete divestment of Russian operations after the geopolitical crisis, aligning with global risk management and compliance. |
| 2024 | Divestment of Vinda stake completed for 19 billion SEK, focusing the portfolio on higher-margin segments and improving balance sheet metrics. |
| 2025 | Essity records a best-ever adjusted EBITA margin of 14.2 percent in H1 2025, reflecting portfolio optimization and cost discipline. |
Demographics and Market Demand
Global aging and rising hygiene awareness support long-term demand for incontinence, wound care and tissue products; analysts foresee steady volume growth in developed markets and faster expansion in select emerging markets.
Sustainability Targets
Essity targets net-zero emissions by 2050 and aims for 100 percent recyclable packaging by 2030, guiding R&D and capital allocation toward circular materials and energy efficiency.
Innovation and Digitalization
Roadmap emphasizes sustainable product innovations and digital health services such as smart incontinence solutions, with increased R&D spend enabled by a stronger balance sheet post-Vinda divestment.
Capital Allocation and M&A
Leadership signals bolt-on acquisitions in Medical Solutions and a focus on higher-margin segments; reduced debt-to-equity and the 19 billion SEK Vinda proceeds support dividends and strategic investments.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Competitive Landscape of Essity Company?
- What is Growth Strategy and Future Prospects of Essity Company?
- How Does Essity Company Work?
- What is Sales and Marketing Strategy of Essity Company?
- What are Mission Vision & Core Values of Essity Company?
- Who Owns Essity Company?
- What is Customer Demographics and Target Market of Essity Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.